D05.0

Clinical Causes: Genetic factors and family history of breast cancer Hormonal influences, such as prolonged exposure to estrogen Age-related changes in breast tissue Previous benign breast conditions Lifestyle factors, including alcohol consumption and obesity

Key Symptoms: Typically, LCIS does not cause noticeable symptoms or lumps Sometimes found incidentally during routine breast imaging In rare cases, may be associated with areas of thickening or atypical changes in the breast tissue

Diagnosis Path: LCIS is often discovered through screening procedures such as mammograms, particularly when radiologists note abnormal breast tissue or microcalcifications. Confirmatory diagnosis is made via a biopsy, where a tissue sample from the breast is examined microscopically. During the biopsy, pathologists look for characteristic abnormal cell growth within the lobules. Additional imaging tests like ultrasound or magnetic resonance imaging (MRI) may be used to evaluate the extent of breast tissue involvement and to plan further management.

Treatment Protocols: Management of LCIS primarily involves careful monitoring and risk reduction strategies. Common approaches include: - **Active surveillance:** Regular clinical breast exams and scheduled imaging tests, like mammograms, to monitor the condition. - **Chemoprevention:** Use of medications such as tamoxifen or raloxifene to reduce the risk of developing invasive breast cancer. - **Surgical options:** In some cases, especially when LCIS is found in a localized area or if there are other risk factors, surgeons may recommend removing the affected tissue. Decision-making about treatment plans depends on individual risk factors, overall health, and personal preferences. A healthcare provider will tailor recommendations accordingly, emphasizing the importance of ongoing surveillance.